SJÖGREN SENDROMUNDA İMMUNSUPRESİF TEDAVİ
PDF

Other

SJÖGREN SENDROMUNDA İMMUNSUPRESİF TEDAVİ

J Turk Soc Rheumatol 2009;1(1):35-41
PDF
Permissions

Abstract

Sjogren syndrome is considered as one of the prototype autoimmune diseases. Although primary inflammation site in SS is exocrine glands other involvements may also be observed. Besides local application choices, immunosuppressive therapy in patients with extrag-landularin volvement is generally treatment of choice. This may be accomplished by traditional immunosuppressive agents such as hydroxychloroquine, methotrexate or azathioprin. Biological treatments are chosen for patients resistant to conventional immunosuppressive treatment. These treatment options will be discussed in this review.